Latisse®

Latisse® is the latest eyelash enhancer distributed by Allergan, the medical giant behind Botox® and Juvederm®. It is the “first and only FDA approved eyelash-growth treatment. The drug is designed for the treatment of hypotrichosis i.e. inadequate eyelashes.

When applied to the base of the upper eyelashes once daily, Latisse® maintains their growth phase, producing longer, thicker lashes and more of them. The effects of Latisse® are not permanent, so patients have to keep using it or their lashes will return to normal.

Allergan discovered Latisse® inadvertently during a clinical trial for a known glaucoma treatment called Lumigan. When patients reported that Lumigan produced significantly longer eyelashes, Allergan began investigating the drug for cosmetic use.

The results of Latisse® require about 1 month to recognize. According to Allergan, full results are seen at 4 months.

Call us for more info and special introductory pricing for Latisse®!